Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in P...
Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy : A Multicenter Phase II Study
About this item
Full title
Author / Creator
Publisher
Basel: Karger
Journal title
Language
English
Formats
Publication information
Publisher
Basel: Karger
Subjects
More information
Scope and Contents
Contents
To evaluate the efficacy and tolerance of capecitabine (CAP) given every other week and biweekly oxaliplatin (OX; modified CAPOX regimen) in patients with advanced colorectal cancer previously treated with irinote- can-based frontline chemotherapy.
Sixty-seven patients were enrolled; the median age was 62 years and 62 (92.5%) had a performance s...
Alternative Titles
Full title
Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy : A Multicenter Phase II Study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_18544957
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_18544957
Other Identifiers
ISSN
0030-2414
E-ISSN
1423-0232
DOI
10.1159/000138977
